Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06657183 · ClinicalTrials.gov registry record · NA
ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
A NA study of Febrile Neutropenia, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06657183 is a NA study of Febrile Neutropenia that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06657183, a NA study of Febrile Neutropenia, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Undergoing cancer treatment comes with various risks and side effects. This clinical trial aims to reduce those risks and side effects through continuous monitoring of vital signs and blood levels. The goal is to see if potential side effects can be identified and treated sooner. During this study, participants will wear an Alio Smartpatch™. The Alio Smartpatch™ is a wireless remote monitoring system. This device will measure participants' vital signs and blood levels. Participants will also be asked to use continuous glucose monitors to measure their glucose levels. The data collected on each participant from these devices will be remotely monitored at all times by clinical staff at a company known as Quantify Remote Care. If a participant's results look like they are experiencing a side effect, the participant will be contacted immediately by Quantify Remote Care team. The Quantify Remote Care team will function as an extension of the participant's cancer clinical team and will relay any significant issues back to them. Quantify Health also provides dietary and mental health support as needed for all participants.
Conditions Studied
Interventions
- DEVICE Alio Smart Patch™
Study Locations (1)
Ohio
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-06 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06657183
The ClinicalTrials.gov registry entry for NCT06657183 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Febrile Neutropenia appearing as the primary indexed condition, and to 1 intervention - of which Alio Smart Patch™ is the first listed.
NCT06657183 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06657183 about?
NCT06657183 is a clinical study titled "ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy". Undergoing cancer treatment comes with various risks and side effects. This clinical trial aims to reduce those risks and side effects through continuous monitoring of vital signs and blood levels. The goal is to see if potential side effects can be identified and treated sooner. During this study,...
What is the current status of trial NCT06657183?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-06. Estimated completion is 2026-10.
What conditions does trial NCT06657183 study?
This clinical trial studies the following conditions: Febrile Neutropenia.
What interventions are being tested in trial NCT06657183?
The interventions under investigation include: Alio Smart Patch™ (DEVICE).
Who is sponsoring clinical trial NCT06657183?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06657183 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Febrile Neutropenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.